Lv2
110 积分 2023-01-29 加入
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
15天前
已完结
Nasal epithelial gene expression identifies relevant asthma endotypes in the ATLANTIS study
4个月前
已完结
Evaluating the Clinical Utility of Small Airway Function Assessment for Early Diagnosis of GOLD Stage 0 Chronic Obstructive Pulmonary Disease
4个月前
已完结
Safety and tolerability of ferric carboxymaltose (FCM) for treatment of iron deficiency in patients with chronic kidney disease and in kidney transplant recipients
5个月前
已完结
Economic Evaluation of Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate for the Treatment of Moderate to Very Severe Chronic Obstructive Pulmonary Disease in China Using a Semi-Markov Model
6个月前
已完结
Budesonide/Glycopyrrolate/Formoterol Fumarate Co-suspension Metered Dose Inhaler: A Triple Therapy for the Treatment of Chronic Obstructive Pulmonary Disease
6个月前
已完结
Chronic obstructive pulmonary disease in over 16s: diagnosis and management
7个月前
已关闭
COPD detection in lung cancer screening programmes: “hitting two birds with one stone”
7个月前
已完结
Bayesian or frequentist: there is no question when comparing single-inhaler triple therapies via network meta-analysis. Focus on fluticasone furoate/umeclidinium/vilanterol fixed-dose combination in chronic obstructive pulmonary disease
10个月前
已完结
First Real-World Evidence on High Dose Strength of Extrafine Single-Inhaler Triple Therapy in Asthma Patients after Three Months of Treatment – TriMaximize Study
10个月前
已关闭
皖公网安备34019202002308
